Corcept Therapeutics Competitors and Similar CompaniesClear all

Corcept Therapeutics's competitors and similar companies include ASLAN Pharmaceuticals.
Corcept Therapeutics
Corcept Therapeutics
Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
Type
Type
Public
Type
Public
Tags
Locations
Locations
Menlo Park, US HQ
Locations
SG HQ
Collingwood, AU
Employees
Employees
20624% increase
Employees
35
Valuation ($)
Valuation ($)
4.8 b
Valuation ($)
1.7 m

Financial

Revenue (est.)
Revenue (est.)
$482.4m (FY, 2023)
Revenue (est.)
$12m (FY, 2023)
Cost of goods
Cost of goods
$6.5m (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
$475.9m (FY, 2023)
Gross profit
$12m (FY, 2023)
Net income
Net income
$106.1m (FY, 2023)
Net income
($44.2m) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 80.1m
Total funding raised
$ 100m
For sources of this data, please see the company profile

View Company Profiles

ASLAN Pharmaceuticals
HQ
SG
Employees
35

ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.

View company